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Objectives: To determine population-based risks of adverse effects on hearing and well-2 
being outcomes associated with unilateral hearing impairment. 3 
Design: A group of 40-69-year-old adults (n = 861) who reported being able to hear only in 4 
one ear and having speech reception thresholds (SRTs) in noise indicating normal hearing in 5 
that ear (SRTN/ ) was selected from the UK Biobank cohort. The UK Biobank participants 6 
with SRTs indicating either normal (SRTN/N, n = 95,514) or symmetrically impaired hearing 7 
in both ears (SRTI/I, n = 17,429) were selected as comparison groups. Self-reported difficulty 8 
following conversations in noise, tinnitus presence, feelings depressed, lonely, unhappy, and 9 
being in poor health or dissatisfied with health were selected as hearing and well-being 10 
outcomes. Logistic regression models were used to evaluate the risks of reporting adverse 11 
outcomes associated with SRTN/  compared to SRTN/N and SRTI/I whilst controlling for 12 
numerous factors linked to hearing and general health.  13 
Results: People with SRTN/  were significantly more likely to report difficulties following 14 
conversations in noise (Odds Ratio = 10.61, 95% Confidence Interval = 8.83 to 12.75), 15 
tinnitus (4.04, 3.51 to 4.66), poor health (1.35, 1.15 to 1.58), health dissatisfaction (1.22, 1.00 16 
to 1.47), and loneliness (1.28, 1.08 to 1.51) compared to people with SRTN/N. Well-being 17 
outcomes were similar in the SRTN/  and SRTI/I groups. However, difficulties following 18 
conversations in noise (5.35, 4.44 to 6.44) and tinnitus presence (2.66, 2.31 to 3.08) were 19 
significantly more likely with SRTN/  than with SRTI/I. The SRTN/  was associated with 20 
increased risk of self-reported poor health by 18% (Relative Risk = 1.18, 95% Confidence 21 
Interval = 1.06 to 1.32) and loneliness by 24% (1.24, 1.07 to 1.43) compared with SRTN/N. 22 
The risk of reporting difficulties following conversations in noise increased by 64% (1.64, 23 




of SRTN/  on reporting poor health was similar to that from having other health problems 1 
such as hypertension or high cholesterol. 2 
Conclusions: The large increases in the risks of reporting adverse hearing-related outcomes 3 
associated with unilateral hearing impairment suggest its specific impact on hearing function 4 
in everyday situations. The increased risk of loneliness and poor health indicates that one 5 
normally functioning ear is also insufficient to protect against the adverse psychosocial 6 
impacts of unilateral hearing impairment. This impact was still significant after controlling 7 
for various health-related factors and can lead to perception of poor health comparable to that 8 
with having medical problems contributing to life-threatening conditions such as heart 9 
disease. The findings suggest the need for effective interventions to address the hearing-10 





Health satisfaction, happiness, mental health and social relationships are among things that 2 
matter most to people and their well-being (Balestra et al. 2017; Office for National Statistics 3 
2019). Population-based studies suggest significant associations between hearing impairment 4 
and negative health, well-being and hearing-related outcomes (Agrawal et al. 2008; Davis 5 
1989; Dawes et al. 2014b; Golub et al. 2018; Wilson et al. 1999). Hearing loss is associated 6 
with communication difficulties in noisy situations, listening effort and fatigue (Alhanbali et 7 
al. 2017; Gatehouse & Noble 2004), which can contribute to social isolation, anxiety, and 8 
depression (Arlinger 2003; Heffernan et al. 2016). A Lancet commission has also identified 9 
hearing loss as the mid-life factor associated with the highest population attributable risk for 10 
all-cause dementia (Livingston et al. 2017). Therefore, successful clinical management of 11 
hearing loss may improve both physical and mental health which are important predictors of 12 
adult well-being (Layard et al. 2014). 13 
There is limited evidence from population-based studies about the impact of unilateral 14 
or single-sided deafness (SSD) characterised by audiometrically normal hearing in one ear 15 
and severe or profound deafness in the other ear (Baguley et al. 2006; Golub et al. 2018; Lin 16 
et al. 2011a). Findings from small-scale studies suggest difficulties following conversations 17 
in noise with unilateral hearing impairment even when the speech perception in the healthy 18 
ear   which may be due to reduced ability to localise and separate talkers of interest 19 
from background noise (Bess et al. 1986b; Douglas et al. 2007; Firszt et al. 2017; Newton 20 
1983; Rothpletz et al. 2012; Slattery & Middlebrooks 1994; Vannson et al. 2015; Vannson et 21 
al. 2017). These adverse hearing-related outcomes may in turn lead to social isolation and 22 
depressive symptoms (Giolas & Wark 1967; Lucas et al. 2018; Sano et al. 2013; Wie et al. 23 
2010), and affect educational attainment and emotional well-being in children (Bess et al. 24 




quality of life (Arlinger 2003; Wie et al. 2010), which can be further adversely affected by a 1 
sudden and unexplained onset as in SSD (Baguley et al. 2006; Carlsson et al. 2011). 2 
While current evidence suggests negative impact of unilateral hearing impairment on 3 
well-being, the risks associated with having access to normal speech perception in only one 4 
ear for hearing and well-being outcomes have not yet been evaluated in population-based 5 
studies. Moreover, available evidence does not allow an evaluation of the relative impact of 6 
unilateral hearing impairment with respect to other health-related problems such as 7 
cardiovascular disease that may be comorbid and associated with hearing loss (Cruickshanks 8 
et al. 1998; Dawes et al. 2014a). As these factors may also have an adverse effect on well-9 
being their inclusion could provide wider context for the implications of unilateral hearing 10 
impairment and related clinical practice. 11 
The aim of the present study was to evaluate the risks of adverse hearing and well-12 
being outcomes in a group of 40-69 years old UK Biobank participants who reported being 13 
able to hear in only one ear indicative of unilateral deafness, and having speech reception 14 
thresholds (SRTs) in noise indicative of normal hearing in their better ear (SRTN/ ). The 15 
study compared the outcomes in the SRTN/  group with those from the UK Biobank 16 
participants whose speech perception was indicative of either normal (SRTN/N) or impaired 17 
hearing (SRTI/I) in both ears. The importance of having only one functionally normal ear was 18 




MATERIALS AND METHODS 1 
UK Biobank resource 2 
UK Biobank is a resource of health data from >500,000 people aged 40 69 years (Allen et al. 3 
2014). The UK Biobank participants were identified via the UK National Health Service 4 
(NHS) patient registries and invited to attend one of the 22 UK Biobank Assessment Centres 5 
in the proximity of the  place of residence. The baseline assessment conducted 6 
between 2007 and 2010, included a registration and consenting process, collection of health-7 
related data using a touchscreen questionnaire and tests of hearing and cognitive function, as 8 
well as physical measures and biological samples (e.g. weight and blood samples). The 9 
consenting process and data collection were carried out by or under the supervision of trained 10 
clerical, nursing and healthcare technician staff (UK Biobank 2007). The present study 11 
included baseline data from 113,804 participants who completed a touchscreen questionnaire 12 
and a short test of speech perception in noise. The UK Biobank has ethical approval from the 13 
North West Multi-centre Research Ethics Committee (MREC). Associated research using the 14 




Seven outcome variables were selected from responses to the UK Biobank touchscreen 19 
questionnaire questions that corresponded to concerns reported by people with SSD (Giolas 20 
& Wark 1967; Lucas et al. 2018; Wie et al. 2010). Two      21 
of the questionnaire described     : whether participants 22 
experienced difficulties following conversations in the presence of background noise or had 23 
tinnitus (see Supplemental Digital Content Table ST1). Five further questions from the 24 




relevant domains of well-being and included self-reports on depression, health rating, 1 
satisfaction with health, happiness and loneliness. These measures were framed in a general 2 
context without reference to hearing and were always asked before any questions about 3 
hearing. Responses were recoded as binary variables indicating the presence or absence of a 4 
negative outcome on well-being or hearing (Table 1). 5 
 6 
*** PLEASE INSERT TABLE 1 HERE *** 7 
 8 
Confounders 9 
D     and age banded into 5-year age groups were extracted as 10 
demographic factors known to be associated with both general health and hearing (Dawes et 11 
al. 2014b). The national quintiles for the Townsend deprivation index score were used as a 12 
demographic measure quantifying an increase in material deprivation status of the population 13 
(Dawes et al. 2014b; Norman 2010). A subset of data from the questionnaire and physical 14 
measures conducted as part of the UK Biobank baseline assessments were also selected to 15 
determine 13 additional factors that may have influenced the outcomes due to their known 16 
associations with general health, well-being, or hearing (Dawes et al. 2014a). These data 17 
included self-reports about the  ethnic background, physical activity levels, 18 
illnesses or specific medication use as evidence of hypertension, high cholesterol, 19 
cardiovascular disease or diabetes, as well as information about tobacco and alcohol 20 
consumption, the use of ototoxic medication, and exposure to loud noise or music. The data 21 
also included physical measurements of body mass index (BMI), pulse wave arterial stiffness 22 
index (PWASI), and blood pressure as supporting evidence of hypertension (see 23 




responses on the self-report measures or used as continuous variables for physical measures 1 
(BMI, PWASI) similar to our previous studies (Dawes et al. 2014a). 2 
 3 
Speech in noise perception assessment 4 
Participants who did not indicate being completely deaf or a cochlear implant user in the 5 
touchscreen questionnaire were asked to complete the Digit Triplets Test (DTT)  a short test 6 
of speech perception in noise (Dawes et al. 2014b; Smits et al. 2004; UK Biobank 2012). The 7 
DTT was completed at ten UK Biobank assessment centres by 164,770 UK Biobank 8 
participants (Dawes et al. 2014b). Participants who wore hearing aids were asked to remove 9 
them for the DTT. Each ear was assessed separately using circumaural headphones 10 
(  D25). A        selected I     11 
the right/left  response option at the beginning of the test indicating potential unilateral 12 
deafness. 13 
The stimuli were presented at a comfortable level set by the participant. The speech 14 
material comprised 15 monosyllabic digit triplets (e.g. 1-3-9). The triplets were presented in a 15 
spectrally shaped noise that was matched to the complete set of nine digits (0 9, excluding 16 
  7   0    ). The noise level varied adaptively between the 17 
presentation trials but was limited such that the signal-to-noise ratios (SNRs) did not exceed 18 
the minimum of 12 dB and maximum of +8 dB. The mean SNR from the last eight triplets 19 
defined the speech reception threshold (SRT) in noise and was used as a measure of the 20 
  .      SNR at which the participant can 21 
report all three successively presented digits accurately against a noise background on 50% of 22 
presentation trials. A more negative SRT score corresponds to an ability to identify digit 23 




Several studies have shown that DTT SRTs correlate well with the average pure-tone 1 
thresholds and have high specificity and sensitivity (about 0.9) for distinguishing individuals 2 
with normal and impaired hearing (Jansen et al. 2013; Smits et al. 2004; Vlaming et al. 2014). 3 
The above characteristics of the DTT, better ecological validity due to the assessment of 4 
speech perception in noise as the most commonly reported complaint with hearing 5 
impairment (Action on Hearing Loss 2011; Smits et al. 2013) and ease of administration 6 
compared to pure-tone audiometry (Jansen et al. 2013), enabled a quantifiable assessment of 7 
hearing function in a large cohort of the UK Biobank participants. The high specificity and 8 
sensitivity of the DTT is typically achieved by an appropriate choice of cut-off values for 9 
differentiating between individuals with normal and impaired hearing based on the normative 10 
DTT SRT data obtained in these populations (Smits & Houtgast 2005; Vlaming et al. 2011). 11 
In a similar way, the normative data obtained from a sample of 20 young adults with 12 
clinically normal hearing (   25 dB HL from 0.25 to 8 kHz) who 13 
performed the UK Biobank DTT were used to assess the SRT variability and cut-offs to 14 
develop performance categories on the UK Biobank DTT (Dawes 2013; Dawes et al. 2014b). 15 
The normative data suggested a better ear mean SRT of 8 dB SNR (Standard Deviation, 16 
SD = 1.24) and categories  (SRT < 5.5 B N ),  (   5.5 and 17 
 3.5 B N )   (  > 3.5 dB SNR), which can be used as indicators of 18 
hearing impairment in the UK Biobank participants (Dawes et al. 2014a; Dawes et al. 2015; 19 
Dawes et al. 2014b; Moore et al. 2014; Pierzycki et al. 2016; Rönnberg et al. 2014; Rudner et 20 
al. 2016). 21 
 22 
Participant groups 23 
The study group and two comparator groups were selected based on their hearing 24 




avoid the inclusion of any cases where the DTT results could have been attributable to non-1 
compliance or equipment failure, 849 participants with the poorest possible SRT score of 2 
+8 dB SNR in either ear were excluded (Pierzycki et al. 2016). The study group was selected 3 
from participants whose overall results suggested unilateral hearing impairment similar to 4 
SSD (self-reported ability to hear in only one ear and SRT in noise for that ear indicative of 5 
normal hearing; < 5.5 dB SNR). As the DTT was not performed in the contralateral ear, the 6 
group was referred to as SRTN/ . 7 
The outcomes reported in the SRTN/  group were compared to those reported in a 8 
group of participants with SRTs indicative of bilaterally normal hearing, SRTN/N (i.e. 9 
< 5.5 dB SNR in both ears). To further increase the specificity in the SRTN/N group, 10 
participants in that group who reported using hearing aids were excluded. A second 11 
comparison group, SRTI/I, comprised people with SRTs indicative of bilaterally symmetric 12 
hearing impairment (i.e.  5.5 dB SNR in both ears). The SRTI/I group only included 13 
participants who had abnormal SRTs that differed by <4.6 dB SNR between the ears to avoid 14 
the inclusion of participants with potentially extreme forms of asymmetry in hearing 15 
function. A    4.6 dB SNR was considered atypical as it fell more than two 16 
standard deviations away from the average SRT difference between the ears in the UK 17 
Biobank sample with SRTs indicating bilateral hearing impairment. 18 
 19 
*** PLEASE INSERT FIGURE 1 HERE (STUDY GROUPS) *** 20 
 21 
Data analysis 22 
Participant characteristics were summarised using descriptive statistics. Prevalence estimates 23 
were standardised by age-band and sex to the whole UK biobank cohort (n = 500,097). 24 




R version 3.5.0. Questionnaire responses P     or D     1 
treated as missing data. These responses could not be assumed missing completely at random 2 
      P     response option (see Supplemental Digital 3 
Content). Therefore, missing data in all outcome and predictor variables used in the models 4 
were accounted for by 100 multiple imputations by chained equations using the package 5 
mice  in R with predictive mean matching method and 5 iterations (Sterne et al. 2009; van 6 
Buuren & Groothuis-Oudshoorn 2011). 7 
Separate binomial logistic models were used to calculate the odds of reporting of each 8 
outcome in the SRTN/  or SRTI/I groups compared to the SRTN/N group, and SRTN/  compared 9 
to the SRTI/I group (see Supplemental Digital Content for full model results). The models 10 
controlled for sex, age-band, interaction between sex and age-band, material deprivation 11 
score as demographic factors, and the 13 factors related to general health, well-being or 12 
hearing described above. Results were considered statistically significant if p < 0.05. Results 13 
were presented as odds ratios derived from regression models, which were subsequently 14 
converted to absolute and relative risks. The odds ratio is a measure of the effect size defined 15 
as the ratio between the odds of a specific outcome occurring in a diseased group compared 16 
to the odds of that outcome occurring in a comparator group (Grant 2014). By definition, the 17 
odds ratio >1 indicates a higher likelihood of the outcome occurring in the diseased group. 18 
The absolute risk describes the probability of developing a specific outcome in a given group, 19 
while the relative risk describes the ratio of the risk (probability) of the outcome in the 20 
diseased group and a comparator group. Therefore, a relative risk >1 would denote a greater 21 
risk (probability) of the outcome occurring in the diseased than in the comparator group. 22 
A distribution of absolute risks across sex, age-bands, and material deprivation 23 
quintiles was derived for each of the hearing and well-being outcomes using the raw data 24 




for absolute risks were obtained using marginal standardisation with corresponding 95% 1 
confidence intervals based on the distribution of standardised risks (Grant 2014; Muller & 2 
MacLehose 2014). Standardised relative risks with  95%   were 3 
calculated using marginal structural binomial regression modelling to avoid potential 4 
instability of estimation due to stratification by a large number of confounders included in the 5 





Participant characteristics 2 
Table 2 shows the characteristics of participants. When considering the prevalence compared 3 
to the total UK Biobank sample standardised for age-band and sex, SRTN/ , indicating 4 
unilateral hearing impairment, was found in 0.5% and SRTI/I, indicating a symmetric bilateral 5 
hearing impairment, in 1.04%   K B  . The mean SRT score in the 6 
SRTN/N   8.08 dB (SD = 0.96)      7.01 dB (SD = 0.81) for the 7 
worse ear. The mean SRT scores in the SRTI/I   4.61 dB (SD = 1.36) and 8 
3.39 dB (SD = 1.81) in the better and worse ears, respectively. The mean SRT score for the 9 
only tested ear of participants in the SRTN/  group was 7.00 dB (SD = 0.90). There was a 10 
higher prevalence of older adults in the SRTN/  and SRTI/I groups with approximately double 11 
the proportion of 65 69-year-olds compared to the SRTN/N group. This difference may have 12 
led to lower SRT scores for the normally functioning ears in the SRTN/  compared to the 13 
SRTN/N group (Table 2). The distribution of material deprivation scores was similar across all 14 
groups and age-bands. 15 
 16 
*** PLEASE INSERT TABLE 2 HERE *** 17 
 18 
Associations with hearing and well-being outcomes 19 
Table 3 shows the odds ratios with 95% confidence intervals for the self-reported outcomes 20 
in the SRTN/  and SRTI/I groups compared to the SRTN/N group, and for the SRTN/  compared 21 
to the SRTI/I group. Well-being outcomes showed a moderate effect of hearing impairment 22 
and participants in the SRTN/  group were significantly more likely to report being in poor 23 
health, dissatisfied with health and lonely compared to those in the SRTN/N group. The 24 




groups. However, adverse hearing-related outcomes were more likely to be reported in the 1 
SRTN/  compared to both the SRTN/N and SRTI/I groups. Difficulties following conversations 2 
in noise were almost 10 times more likely with the SRTN/  compared to SRTN/N and 5 times 3 
more likely compared to SRTI/I. Participants with SRTN/  were also significantly more likely 4 
to report tinnitus than those in both SRTN/N and SRTI/I groups. 5 
Figure 2 illustrates the relative effects (odds ratios and 95% confidence intervals) of 6 
SRTN/  and other demographic, health and lifestyle predictors of self-reported poor health 7 
(see model outputs in Supplemental Digital Content for other outcomes). Females, older age 8 
and white ethnic groups, current drinkers and those reporting moderate exercise levels were 9 
less likely to report being in poor health. Higher levels of material deprivation, and the 10 
presence of all other health and lifestyle factors were associated with higher likelihood of 11 
reporting poor health. 12 
Table 4 shows estimated standardised relative risks associated with hearing 13 
impairment for the SRTI/I and SRTN/  groups. Compared to the absolute risk in those with 14 
SRTN/N, there was a significant increase in the risk of self-reported loneliness and poor health 15 
in those with SRTN/ . The risk of difficulties following conversations in noise associated with 16 
SRTN/  increased by about 161% and 64% compared to the absolute risk of this outcome 17 
occurring in the SRTN/N and SRTI/I groups, respectively. The risk of reporting tinnitus with 18 
SRTN/  increased even more compared to the SRTN/N (182%) and the SRTI/I group (84%). 19 
 20 
*** PLEASE INSERT TABLE 3 HERE *** 21 
*** PLEASE INSERT TABLE 4 HERE *** 22 





Key findings 2 
The UK Biobank data suggests that hearing function indicative of unilateral hearing 3 
impairment is associated with significant increase in the likelihood of reporting adverse 4 
hearing-related outcomes. The large increase in the risk of difficulties following 5 
conversations in noise and tinnitus presence was observed when compared to both those with 6 
hearing function indicating normal or symmetrically impaired hearing in both ears. The risks 7 
of reporting adverse well-being outcomes were similar in those with unilateral and with 8 
bilateral symmetric hearing impairment. However, the risks of self-reported loneliness and 9 
poor health were somewhat larger with unilateral than bilateral hearing impairment when 10 
compared to absolute risks of those outcomes occurring with bilaterally normal hearing. 11 
 12 
Hearing outcomes with unilateral hearing impairment 13 
The significant increases in the likelihood of reporting difficulties following 14 
conversations in noise associated with unilateral hearing impairment were most likely 15 
connected with the loss of binaural hearing. Difficulty localising sound sources has been 16 
associated with asymmetric hearing loss (Noble & Gatehouse 2004), and could have 17 
contributed to these increases as their daily-life impact on   hearing ability can be 18 
disproportionate to the degree of hearing loss (Gatehouse & Noble 2004). Localisation 19 
difficulties could be particularly acute when hearing in one ear is lost completely as with SSD 20 
(Wie et al. 2010). However, there is also contrary evidence of good monoaural sound 21 
localisation in people with unilateral impairment (Agterberg et al. 2014; Firszt et al. 2015; 22 
Slattery & Middlebrooks 1994). 23 
Therefore, another contributing factor could be associated with the difficulty to listen 24 




relies on comparing information from two ears (Colburn et al. 2006). Difficulties with the 1 
effective use of selective attention for segregating competing sounds into separate auditory 2 
objects could be negatively affected by the peripheral and central consequences of hearing 3 
impairment (Dai et al. 2018; Shinn-Cunningham & Best 2008). However, access to and 4 
comparison of auditory information from two ears, plausibly even with bilaterally impaired 5 
but symmetric hearing function, could give a binaural advantage for spatial separation of 6 
competing sounds that would not be available in monoaural listening conditions (Marrone et 7 
al. 2008). Selective listening with unilateral hearing impairment could also be predicted by 8 
head shadow effects which could negatively affect speech perception independently of 9 
individual localisation ability and be particularly acute when the target and masking sounds 10 
are collocated (Rothpletz et al. 2012). Therefore, experience of poor localisation and selective 11 
listening could have both influenced the large increases in the risk of self-reported difficulties 12 
following conversations in noise in the SRTN/  compared to both SRTN/N and SRTI/I groups. 13 
The present findings could also be connected with the choice of measures used to 14 
evaluate hearing ability and define the study groups. A monoaural test of speech perception 15 
such as the UK Biobank DTT can be used to simulate the lack of auditory input in one ear in 16 
SSD (Williams et al. 2017), and suggests that UK Biobank participants had to rely mostly on 17 
monoaural cues to segregate the spoken digits from background noise. This scenario mimics 18 
the largest difficulty of separating the target from competing speech observed in monaural 19 
listening or when both signals are collocated (Marrone et al. 2008). This suggests that the 20 
DTT SRTs measured in noise were more relevant to the lived experience with unilateral 21 
hearing impairment and a better predictor of self-reported difficulty following conversations 22 
in noise in the SRTN/  group. Indeed, a significantly higher proportion of self-reported 23 
difficulties following conversations in noise was found in the SRTN/  group (83%) compared 24 




hearing function on the DTT (55% on average; Supplemental Digital Content Fig. SF1). This 1 
significant increase suggests a categorical change in the perceived impact from high levels of 2 
hearing impairment or deafness in the worse ear in the SRTN/  group, and partly explains the 3 
significant increases in the risks of reporting difficulties following conversations in noise in 4 
the SRTN/  compared to the SRTI/I and SRTN/N groups. 5 
Both the SRTN/  and SRTI/I were also associated with significantly greater risks of 6 
reporting tinnitus compared to SRTN/N, consistent with hearing loss being one of the major 7 
risk factors for developing tinnitus (Gopinath et al. 2010; Shargorodsky et al. 2010), and 8 
consequences of SSD (Lucas et al. 2018). However, tinnitus appears to be more prevalent in 9 
those with acquired SSD (Lee et al. 2017), and better hearing thresholds in the contralateral 10 
ear have been suggested as a predictive factor of acute tinnitus onset in patients with sudden 11 
idiopathic sensori-neural hearing loss (Lee et al. 2015). The information about aetiology of 12 
deafness was not available for the present sample. However, given that sudden onset of 13 
deafness is one of the most common causes of acquired unilateral hearing loss (Baguley et al. 14 
2006), having one normally functioning ear in the SRTN/  group could have contributed to 15 
their larger risks of reporting tinnitus compared with the SRTI/I group. 16 
 17 
Impact of unilateral hearing impairment 18 
The risks of loneliness and poor health were somewhat larger in the unilateral than 19 
bilateral hearing impairment when compared to the corresponding absolute risks with normal 20 
hearing function, but the increase in risks in both groups was generally consistent with a 21 
reduced sense of being able to cope with noisy situations and having a smaller social group 22 
with hearing loss (Kramer et al. 2002). The increased risk of reporting poor health was also 23 
compatible with the impaired health-related quality of life with SSD (Sano et al. 2013; 24 




A smaller number of adverse well-being outcomes and the lack of significant 1 
associations with self-reports of feeling depressed or unhappy in unilateral compared to 2 
bilateral hearing impairment could be related to a specific interaction between the severity of 3 
the symptoms and the aetiology or duration of deafness (Kurz et al. 2019). Psychosocial 4 
consequences of congenital deafness may be less severe as people adapt to their adverse 5 
hearing-related outcomes over time (Carlsson et al. 2015). The large risks associated with 6 
hearing-related outcomes found in the present study were compatible with an acute onset of 7 
SSD resulting from idiopathic sudden sensorineural hearing loss (Sano et al. 2013), or 8 
surgical removal of benign acoustic tumours (Kuhn et al. 2011). Both aetiologies can lead to 9 
        (Carlsson et al. 2011) and negative emotional 10 
responses such as the fear of losing hearing in the other ear (Sano et al. 2013). The 11 
information about  aetiology and duration of deafness or audiological 12 
interventions was not available. However, these factors may have contributed to hearing-13 
related outcomes (Carlsson et al. 2015; Kurz et al. 2019; Slattery & Middlebrooks 1994), and 14 
be required for characterising the risks of adverse well-being outcomes and the impact on 15 
quality of life in unilateral hearing impairment (Carlsson et al. 2011; Kitterick et al. 2015; 16 
Subramaniam et al. 2005; Vannson et al. 2015). 17 
The large-scale UK Biobank health data allowed controlling for numerous 18 
demographic, lifestyle, hearing, health and well-being characteristics (Dawes et al. 2014a; 19 
Dawes et al. 2014b; Lin et al. 2011b; Wilson et al. 1999), facilitating comparisons between 20 
the impact of unilateral hearing impairment and other significant confounding factors and 21 
health conditions (Fig. 2). For example, the demographic characteristics suggested a similar 22 
effect of material deprivation on poor health ratings to that of unilaterally impaired hearing, 23 
but females, those in older age and white ethnic groups were less likely to report poor health. 24 




difficulties following conversations in noise in the present study (see Supplemental Digital 1 
Content), and higher levels of hearing disability found in other epidemiological studies 2 
(Cruickshanks et al. 1998; Davis 1989; Dawes et al. 2014a). These effects could have been 3 
associated with the   bias in the UK Biobank sample (Fry et al. 2017), or 4 
the complex and comparative nature of self-health ratings observed when including multiple 5 
health indicators in multivariate models (Andersen et al. 2007; Jylhä et al. 2001). 6 
Figure 2 also facilitates a comparison of the impact of unilateral hearing impairment 7 
with that of other significant health conditions. For example, the data from the UK Biobank 8 
sample suggest that the likelihood of reporting poor health with the SRTN/  can be similar to 9 
that associated with having hypertension or high cholesterol, and potentially higher than other 10 
factors associated with poor health such as high blood pressure and previous smoking. 11 
However, self-reports of poor health were less likely with unilateral hearing impairment than 12 
with being a current smoker or having medical conditions such as diabetes and cardiovascular 13 
disease which can be life-threatening (World Health Organization 2018). Therefore, the 14 
relatively higher impact of health conditions such as diabetes and cardiovascular disease may 15 
have been responsible for the moderate effects of unilateral hearing impairment on well-16 
being. 17 
 18 
Strengths and limitations 19 
The major strength of the present study was the use of large-scale UK Biobank data. 20 
Previous studies of the impacts of SSD used relatively small sample sizes or participants with 21 
SSD as their own controls (Kitterick et al. 2015). The UK Biobank resource allowed for the 22 
first time to establish the relative risks of adverse hearing and well-being outcomes in people 23 




impaired hearing function in both ears. Another novel aspect was that the risks were 1 
evaluated whilst controlling for numerous factors associated with poor health and well-being. 2 
However, the UK Biobank sample included only 40 69 year-old adults and previous 3 
studies suggested that it is not representative of the population due to bias towards 4 
recruitment of healthy participants (Fry et al. 2017). However, as the UK Biobank 5 
demographics may be associated with fewer hearing-related problems (Dawes et al. 2014b), 6 
the present findings would rather under- than over-estimate the risks of adverse outcomes 7 
associated with SRTN/ . The prevalence of SSD in the general population is likely to be 8 
higher than that estimated from SRTN/  in the UK Biobank sample. Baguley and colleagues 9 
(2006) estimated about 7500 new cases of acquired unilateral sensori-neural hearing loss of 10 
different aetiologies per year, corresponding to about 0.016% of the UK population. 11 
However, unknown aetiology and history of deafness in the UK Biobank cohort does not 12 
allow estimation of and comparison with the incidence rates found in the previous study. 13 
Direct comparisons with other studies are also difficult due to the use of different 14 
definitions of unilateral hearing loss or SSD. The prevalence of moderate-or-worse unilateral 15 
 ; . .   41 B HL    ,  found to be about 16 
1.5% in the National Health and Nutritional Examination Surveys (NHANES) cohort (Golub 17 
et al. 2018; Lin et al. 2011a). However, about a third (31%) of participants with moderate-or-18 
worse unilateral hearing loss have also reported having difficulty hearing, which was also 19 
reported by the majority of participants in the SRTN/  group (84%). Therefore, the prevalence 20 
of unilateral hearing impairment in the US population may be lower and closer to the 0.5% 21 
prevalence found in the UK Biobank cohort when one considers both the unilaterally 22 
impaired hearing function and self-reported difficulty hearing. 23 
Due to the lack of audiometric thresholds and therefore clinical diagnoses of hearing 24 




function in the better ear using cut-off criteria for SRT in noise similar to previous studies 1 
(Dawes 2013; Dawes et al. 2014b; Smits et al. 2004). While this is a limitation of the present 2 
study, characterisation of hearing using a speech in noise test such as the DTT increased the 3 
ecological validity of the findings compared to the use of pure-tone audiogram (Musiek et al. 4 
2017), and related to the difficulty following conversations in noise as the most common 5 
complaint reported by patients with hearing loss (Action on Hearing Loss 2011; Assmann & 6 
Summerfield 2004; Heffernan et al. 2016). The ecological validity is further supported but 7 
the findings suggesting that difficulties understanding speech in noise may be an early 8 
symptom of dementia (Livingston et al. 2017; Moore et al. 2014). 9 
 10 
Relevance to clinical practice and future studies 11 
The findings suggest that       to protect against adverse outcomes 12 
related to well-being. The results support the notion that a holistic management strategy is 13 
warranted to address both the hearing difficulties and the negative impact on well-being in 14 
unilateral hearing impairment (Gordon et al. 2015; Lucas et al. 2018). Provision of 15 
appropriate support or psychological therapies for this population is in line with the current 16 
action plans for reducing the impact of disabling hearing loss put forward by hearing charities 17 
(Action on Hearing Loss 2011) and the Department of Health in the UK (NHS England and 18 
Department of Health 2015), and globally by the World Health Organisation (Curhan 2019; 19 
Olusanya et al. 2014). However, the large increases in risk of adverse hearing-related 20 
outcomes in the SRTN/  group suggest that current efforts should focus on the development 21 
and provision of effective hearing interventions for unilateral hearing impairment. 22 
It was not possible to assess the type of hearing aid systems used by the UK Biobank 23 
participants, which may have included contralateral routing of signals (CROS) or bone-24 




Kitterick et al. 2016). However, a larger proportion of participants reported using hearing 1 
aids  in the SRTN/  (19%) than the SRTI/I group (8%, see Supplemental Digital Content). As 2 
the risks of self-reported difficulties following conversations in noise and tinnitus were also 3 
significantly higher in the SRTN/  group, it is plausible to assume that this group would be 4 
more likely to seek interventions for their communication problems. Indeed, despite not 5 
meeting typical eligibility criteria due to having one normally functioning ear, patients with 6 
SSD consider cochlear implantation towards restoring binaural hearing and alleviating 7 
tinnitus (Vermeire & Van de Heyning 2009). 8 
There is an increasing body of evidence suggesting a benefit of cochlear implantation 9 
for the alleviation of tinnitus (Arts et al. 2015; Arts et al. 2016; Peter et al. 2019; Van de 10 
Heyning et al. 2008), as well as perception of speech in noise and binaural hearing (Dirks et 11 
al. 2019; Friedmann et al. 2016; Litovsky et al. 2019; Sladen et al. 2017; Távora-Vieira et al. 12 
2013). However, the strength of conclusions about the evidence of the comparative 13 
effectiveness of cochlear implantation, CROS and BAHA systems made by previous reviews 14 
has been limited by inconsistencies in the use and reporting of treatment outcomes (Baguley 15 
et al. 2006; Blasco & Redleaf 2014; Cabral Junior et al. 2016; Kitterick et al. 2016; Peters et 16 
al. 2015). These inconsistencies have focussed recent efforts towards research identifying a 17 
core set of outcomes for use in clinical trials evaluating the effectiveness of interventions for 18 
SSD (Katiri et al. 2020; Van de Heyning et al. 2016). The significant risks of loneliness and 19 
perceptions of poor health found in the present study suggest their importance for patients 20 
and inclusion as outcomes in clinical trials of interventions for SSD in addition to those 21 
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FIGURE CAPTIONS 1 
Figure 1. Schematic of the study groups and the inclusion criteria based on the normative 2 
speech reception threshold (SRT) in noise cut-offs developed for the UK Biobank Digit Triplets 3 
Test (DTT). The SRT descriptors denote: N = ‘normal’, I = ‘impaired’, L/R = left/right ear. 4 




Figure 2. Odds ratios for SRTN/− and other predictors (reference levels in brackets) included in 1 
the regression model for the outcome ‘In poor health’ and comparison group SRTN/N. Error 2 
bars show 95% confidence intervals for the estimates. The solid vertical line indicates the odds 3 
ratio of 1. Odds ratios >1 suggest greater odds of reporting poor health in the SRTN/– than the 4 
SRTN/N group. 5 
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TABLE 1. Definitions of outcomes 1 
Outcome UK Biobank question 
Well-being  
 Over the past two weeks, how often have you felt down, 
Depressed depressed or hopeless * 
No a) Not at all 
No b) Several days 
Yes c) More than half the days 
Yes d) Nearly every day 
  
In poor health In general how would you rate your overall health * 
No a) Excellent 
No b) Good 
Yes c) Fair 
Yes d) Poor 
  
Dissatisfied with health In general how satisfied are you with your health * 
No a) Extremely happy 
No b) Very happy 
No c) Moderately happy 
Yes d) Moderately unhappy 
Yes e) Very unhappy 
Yes f) Extremely unhappy 
  
Lonely Do you often feel lonely * 
Yes a) Yes 
No b) No 
  
Unhappy In general how happy are you * 
A  Di a i fied i h heal h  Response options a  in Di a i fied i h heal h  
  
Hearing  
Has difficulty following  Do you find it difficult to follow a conversation if there is  
conversations in noise background noise (such as TV, radio, children playing) * 
A  Lonely  Response options a  in Lonely  
  
 Do you get or have you had noises (such as ringing or  
 buzzing) in your head or in one or both ears that lasts for 
Has tinnitus more than five minutes at a time * 
Yes a) Yes, now most or all of the time 
Yes b) Yes, now a lot of the time 
Yes c) Yes, now some of the time 
No d) Yes, but not now, but have in the past 
No e) No, never 
* Incl ded op ion  Do no  kno  and Prefer not to answer  ea ed a  mi ing da a. 
  2
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TABLE 2. Characteristics of participants 1 
Characteristic SRTN/N SRTI/I SRTN/  
 % N  % N  % N  
Total participants 84 (95,514) 15 (17,429) 1 (861) 
Male sex 45 (43,315) 46 (7951) 43 (374) 
Age band       
40-44 13 (12,141) 5 (872) 6 (53) 
45-49 15 (14,514) 7 (1219) 8 (68) 
50-54 17 (15,917) 10 (1707) 13 (113) 
55-59 18 (17,377) 15 (2576) 17 (150) 
60-64 23 (22,017) 30 (5190) 28 (240) 
65-69 14 (13,548) 33 (5865) 28 (237) 
Material deprivation       
Quintile 1 39 (36,897) 33 (5675) 33 (281) 
Quintile 2 22 (21,473) 21 (3586) 21 (181) 
Quintile 3 18 (16,878) 17 (3022) 18 (157) 
Quintile 4 15 (13,971) 18 (3135) 18 (151) 
Quintile 5 6 (6154) 11 (1981) 10 (89) 
Missing  (141)  (30)  (2) 
       
Better ear SRT in dB Mean SD Mean SD Mean SD 
40-44 8.28 (0.97) 4.75 (1.31) 7.14 (1.07) 
45-49 8.24 (0.95) 4.75 (1.22) 7.38 (1.02) 
50-54 8.18 (0.97) 4.77 (1.17) 7.13 (0.93) 
55-59 8.07 (0.95) 4.68 (1.34) 6.99 (0.84) 
60-64 7.97 (0.94) 4.63 (1.33) 7.01 (0.95) 
65-69 7.83 (0.93) 4.47 (1.46) 6.78 (0.73) 
Worse ear SRT in dB *       
40-44 7.17 (0.86) 3.59 (1.73)   
45-49 7.14 (0.85) 3.66 (1.66)   
50-54 7.09 (0.83) 3.63 (1.61)   
55 59 7.01 (0.80) 3.52 (1.78)   
60 64 6.91 (0.77) 3.40 (1.79)   
65 69 6.81 (0.73) 3.17 (1.91)   
Data are percentages (counts) unless stated otherwise (% excluding missing data). 
* Worse ear SRTs were not available if only one ear was tested (SRTN/  group). 




TABLE 3. Odds ratios for the association between self-reported hearing and well-being outcomes 1 
 SRTI/I vs SRTN/N  SRTN/  vs SRTN/N  SRTN/  vs SRTI/I 
Outcome OR (95% CI) p  OR (95% CI) p  OR (95% CI) p 
Well-being            
Depressed 1.51 (1.41 to 1.63) <0.001  1.19 (0.88 to 1.60) 0.258  0.79 (0.58 to 1.06) 0.116 
In poor health 1.29 (1.24 to 1.34) <0.001  1.35 (1.15 to 1.58) <0.001  1.05 (0.89 to 1.23) 0.567 
Dissatisfied with health 1.21 (1.15 to 1.27) <0.001  1.22 (1.00 to 1.47) 0.048  1.00 (0.83 to 1.22) 0.960 
Lonely 1.20 (1.15 to 1.25) <0.001  1.28 (1.08 to 1.51) 0.004  1.06 (0.90 to 1.26) 0.476 
Unhappy 1.19 (1.10 to 1.29) <0.001  0.95 (0.68 to 1.34) 0.787  0.80 (0.57 to 1.13) 0.202 
Hearing            
Has difficulty following 
conversations in noise 
1.98 (1.91 to 2.06) <0.001  10.61 (8.83 to 12.75) <0.001  5.35 (4.44 to 6.44) <0.001 
Has tinnitus 1.52 (1.45 to 1.58) <0.001  4.04 (3.51 to 4.66) <0.001  2.66 (2.31 to 3.08) <0.001 
The models adjusted for all confounders used in the regression models. 
CI, confidence interval; I , impai ed;  N , no mal; OR, odd  a io; SRT, peech ecep ion h e hold. 
  2 
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TABLE 4. Absolute and standardised risks associated with normal and impaired hearing 1 
 Absolute risk * Relative risk with impaired hearing **  Absolute risk * Relative risk ** 
Outcome SRTN/N (95% CI) SRTI/I (95% CI) SRTN/  (95% CI)  SRTI/I (95% CI) SRTN/  (95% CI) 
Well-being       
Depressed 0.05 (0.05 to 0.05) 1.47 (1.36 to 1.58) 1.23 (0.90 to 1.68)  0.06 (0.06 to 0.06) 0.89 (0.65 to 1.22) 
In poor health 0.02 (0.02 to 0.02) 1.16 (1.13 to 1.20) 1.18 (1.06 to 1.32)  0.03 (0.03 to 0.03) 1.06 (0.96 to 1.17) 
Dissatisfied with health 0.01 (0.01 to 0.01) 1.17 (1.12 to 1.23) 1.13 (0.95 to 1.34)  0.01 (0.01 to 0.01) 1.06 (0.90 to 1.25) 
Lonely 0.10 (0.10 to 0.10) 1.14 (1.09 to 1.18) 1.24 (1.07 to 1.43)  0.11 (0.11 to 0.11) 1.03 (0.89 to 1.18) 
Unhappy 0.05 (0.05 to 0.05) 1.15 (1.05 to 1.25) 1.00 (0.69 to 1.44)  0.05 (0.05 to 0.05) 0.82 (0.58 to 1.16) 
Hearing       
Has difficulty following 
conversations in noise 
0.17 (0.17 to 0.17) 1.47 (1.44 to 1.51) 2.61 (2.52 to 2.71)  0.31 (0.31 to 0.31) 1.64 (1.58 to 1.71) 
Has tinnitus 0.10 (0.10 to 0.10) 1.40 (1.35 to 1.46) 2.82 (2.58 to 3.09)  0.17 (0.16 to 0.17) 1.84 (1.69 to 2.01) 
* Point estimates and 95% CIs for absolute risks adjusted for age and sex using UK Biobank population data. 
** Rela i e i k  and ob  95% CI  adj ed fo  all confo nde  ed in he eg e ion model . 
CI, confidence interval; I , impaired; N , no mal; SRT, speech reception threshold. 
 2 
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TABLE ST1. Definitions of confounding factors (Dawes et al. 2014a) 
Factor Levels Definition 
Sex Male/Female Self-reported 
Age band 5-year bands in the 40 69 
years old range 
Calculated using self-reported age 
Material deprivation status Score 1 to 5 (from low to 
high material deprivation) 
National quintiles for the Townsend deprivation 
index score calculated using the national census 
 a ea  f  he a ici a  c de 
immediately before joining the UK Biobank 
Ethnicity White/Non-White Self-reported ethnic background 
Moderate exercise Yes/No Self-reported moderate physical activity of 
>10 min on the day before assessment 
Hypertension Yes/No Self-reported hypertension or measured systolic 
blood pressure >140 mm Hg and diastolic blood 
pressure >90 mm Hg 
High cholesterol Yes/No Self-reported high cholesterol or taking 
medication for high cholesterol 
Cardiovascular disease Yes/No Self-reported angina, heart attack, heart failure, 
stroke, transient ischemic attack, intermittent 
claudication, arterial embolism, or deep venous 
thrombosis 
Diabetes Yes/No Self-reported diabetes type 1 or 2 or taking 
insulin for diabetes 
Smoking status Current/Former/Never Self-reported tobacco consumption 
Drinking status Current/Former/Never Self-reported alcohol consumption 
Ototoxic medication use Yes/No Self-reported daily/weekly or monthly use of 
ototoxic medications (loop diuretics, 
aminoglycoside antibiotics, quinine derivatives, 
non-steroidal anti-inflammatories, and 
salicylates) 
Occupational noise exposure Yes/No Self-reports of working in a noisy place where 
one had to shout to be heard 
Loud music exposure Yes/No Self-reports of listening to music for >3 h/week 
at volumes where one needs to shout to be 
heard or to hear others 
Body mass index (BMI) Continuous Weight in kilograms/(Height in metres)2 
Pulse Wave Arterial 
Stiffness Index (PWASI) 




Validation of self-reported deafness in one ear 
Participants in the SRTN/  group reported that they could hear only in their better ear which 
indicated deafness in the worse ear. Therefore, speech reception thresholds (SRTs) in noise 
on the UK Biobank Digit Triplets Test (DTT) were measured only for the better ear in that 
group. The better ear SRTs were indicative of normal hearing based on the cut-off criteria 
derived from the UK Biobank DTT normative data in young, normally hearing adults (Dawes 
2013; Dawes et al. 2014b). To substantiate self-reports about the inability to hear in the worse 
ear, self-reported difficulties following conversations in noise in the SRTN/  group were 
compared to those reported by a group of participants with SRTs indicating high levels of 
hearing impairment in the worse ear. The comparator group, SRTN/I, included participants 
who performed the DTT for both ears and had SRTs indicative of normal hearing in the better 
ear (< 5.5 dB SNR) and impaired hearing in the worse ear (  5.5 dB SNR). Participants 
with the poorest possible SRT of +8 dB SNR in the worse ear, potentially attributable to non-
compliance or equipment failure, were excluded (Pierzycki et al. 2016). Responses to the 
question Do you find it difficult to follow a conversation if there is background noise (such 
a  TV, adi , chi d e  a i g)  in the UK Biobank questionnaire were used as the most 
relevant outcome for comparison of groups defined using a measure of speech perception in 
noise (i.e. DTT SRT). Table ST2 shows participant characteristics in the SRTN/I and SRTN/  
groups. Table ST3 and Fig. SF1 show the proportions of difficulties following conversations 
in noise reported in both groups. The worse ear SRT in the SRTN/I group was presented in 2-
dB-SNR bands for consistency with the normative DTT cut-off criteria (Dawes et al. 2014b), 
and to ensure the inclusion of sufficient number of participants across different levels of 
speech perception ability. Proportions of participants reporting difficulties following 
conversations in noise in the SRTN/I group increased with the increase of the SRT scores in 
the worse ear up to about 1.5 dB SNR indicating  hea i g (Dawes et al. 2014b). The 
proportions reported for worse ear SRT scores larger than 1.5 dB SNR up to the poorest 
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SRT score of +7.75 dB SNR were similar (about 55% on average). About 83% of participants 
in the SRTN/  group reported having difficulty following conversations in noise. This 
proportion was significantly higher than the proportions found in the SRTN/I group, including 
those from participants with the highest SRT scores in their worse ear. 
TABLE ST2. Characteristics of participants in the SRTN/I and SRTN/  groups. 
Characteristic SRTN/I SRTN/  
Total participants  (44,535)  (861) 
Male sex 45 (20,154) 43 (374) 
Age band     
40-44 8 (3,662) 6 (53) 
45-49 10 (4,560) 8 (68) 
50-54 13 (5,844) 13 (113) 
55-59 17 (7,485) 17 (150) 
60-64 28 (12,330) 28 (240) 
65-69 24 (10,654) 28 (237) 
Material deprivation     
Quintile 1 36 (16,008) 33 (281) 
Quintile 2 22 (9,656) 21 (181) 
Quintile 3 18 (7,806) 18 (157) 
Quintile 4 16 (7,170) 18 (151) 
Quintile 5 9 (3,817) 10 (89) 
Missing (count)  (78)  (2) 
     
Better ear SRT in dB Mean SD Mean SD 
40-44 7.31 (0.99) 7.14 (1.07) 
45-49 7.25 (0.96) 7.38 (1.02) 
50-54 7.23 (0.97) 7.13 (0.93) 
55-59 7.16 (0.95) 6.99 (0.84) 
60-64 7.08 (0.92) 7.01 (0.95) 
65-69 7.02 (0.89) 6.78 (0.73) 
Worse ear SRT in dB *     
40-44 4.75 (1.09)   
45-49 4.73 (1.15)   
50-54 4.65 (1.25)   
55 59 4.67 (1.20)   
60 64 4.57 (1.30)   
65 69 4.47 (1.35)   
Data are percentages (counts) unless stated otherwise (% excluding missing data). 
* Worse ear SRTs were not available if only one ear was tested (SRTN/  group). 
I, impaired; N, normal SD, standard deviation; SRT, speech reception threshold. 
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TABLE ST3. Proportions of reported difficulty following conversations in noise. 
Worse ear SRT band (dB SNR) N % (95% CI) 
[ 5.5, 3.5) 13,985 38 (38 to 39) 
[ 3.5, 1.5) 2,349 44 (42 to 45) 
[ 1.5, 0.5) 417 52 (48 to 55) 
[0.5, 2.5) 129 58 (52 to 64) 
[2.5, 4.5) 59 54 (45 to 63) 
[4.5, 6.5) 29 56 (42 to 68) 
[6.5, 8.0) 36 54 (42 to 65) 
CI, confidence interval; SRT, speech reception threshold. 
 
 
Figure SF1. Self-reported difficulties following conversations in noise in the SRTN/I group. 
Error bars show 95% confidence intervals for the proportions. The solid and dashed 
horizontal lines indicate the proportion and the 95% confidence interval reported in the 
SRTN/  group. The inset indicates the number of participants in each worse ear SRT band. 
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Missing data and complete case analysis 
Table ST4 lists the proportions of missing data for the outcome and confounder variables 
used in the regression models. Complete case analyses for the group data suggested an effect 
of the loss of data in the a iab e moderate exercise  he  c a i g unilaterally impaired 
and normal hearing groups. However, removal of that variable from the complete case 
models did not change the findings compared to those from the imputed dataset, apart from 
the effect on di a i fac i  i h hea h  which ceased to be statistically significant (cf. Table 
3). The c f de  de a e e e ci e  a  i c ded i  he fi a  de  d e  i  k  
significant association with health, well-being and hearing impairment (Dawes et al. 2014a), 
and potential influence on data missingness in other variables included in the models. 
TABLE ST4. Proportions of missing data in outcome and confounder variables. 
Model variable N % * 
Depressed 4637 4.07 
In poor health 367 0.32 
Dissatisfied with health 574 0.50 
Lonely 1797 1.58 
Unhappy 662 0.58 
Has difficulty following conversations in noise 2802 2.46 
Has tinnitus 2291 2.01 
Age band 0 0.00 
Sex 0 0.00 
Material deprivation 173 0.15 
Ethnicity 426 0.37 
BMI 2513 2.21 
PWASI 1885 1.66 
Hypertension 0 0.00 
Cholesterol 0 0.00 
Cardiovascular disease 0 0.00 
Moderate exercise 38806 34.10 
Diabetes 0 0.00 
Smoking status 353 0.31 
Drinking status 73 0.06 
Occupational noise exposure 1009 0.89 
Loud music exposure 1662 1.46 
Ototoxic medication use 0 0.00 
* Percentage of the 113804 participants included in the study. 
BMI, Body Mass Index; PWASI, Pulse Wave Arterial Stiffness Index. 
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Hearing aid use 
All participants completing the UK Biobank touchscreen questionnaire were asked the 
question D   e a hea i g aid  f he i e? . Information on hearing aid use did not 
indicate which ear was aided or the type of hearing aid; e.g. whether participants used a 
specialised hearing aid system such as a contralateral routing of signals (CROS) hearing aid 
or a bone-anchored hearing aid (BAHA). However, self-reported hearing aid use was 
analysed and compared between the SRTN/  and SRTI/I groups to establish whether seeking 
help for hearing-related problems would be more likely with unilateral than with a bilateral, 
symmetric form of hearing impairment. About 19% of participants in the SRTN/  group 
reported using hearing aids compared to about 8% reported in the SRTI/I group. Logistic 
regression models controlling for age-band, sex, their interaction and the same health and 
lifestyle factors included in the main analyses (see Methods section) showed that participants 
in the SRTN/  group were significantly more likely to use hearing aids than those in the SRTI/I 
group (odds ratio 2.86, 95% confidence interval 2.37 to 3.45; p < 0.001). The risk associated 
with hearing aid use in the SRTN/  group was about 133% higher (relative risk 2.33, 95% 
confidence interval 1.99 to 2.71) compared to the absolute risk in the SRTI/I group (0.02, 95% 
confidence interval 0.02 to 0.02).  
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TABLE ST5. Model o : o come De e ed , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 3.035 0.117 26.02 8837.94 <0.001 
Group (SRTN/N *)      
SRTI/I 0.413 0.037 11.19 20156.07 <0.001 
SRTN/  0.172 0.152 1.13 32590.02 0.258 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.085 0.073 1.16 39719.76 0.245 
Age band 3 (50 54) 0.152 0.073 2.08 42047.25 0.037 
Age band 4 (55 59) 0.399 0.075 5.29 37134.07 <0.001 
Age band 5 (60 64) 0.818 0.077 10.56 34001.59 <0.001 
Age band 6 (65 69) 1.160 0.091 12.81 22164.43 <0.001 
Sex (male) 0.182 0.072 2.54 38437.57 0.011 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.101 0.042 2.39 35686.22 0.017 
Quintile 3 0.257 0.042 6.08 40801.57 <0.001 
Quintile 4 0.460 0.042 11.07 32392.85 <0.001 
Quintile 5 (most deprived) 0.638 0.049 13.14 25022.46 <0.001 
Ethnicity white (non white) 0.711 0.042 16.75 13323.67 <0.001 
Higher BMI (continuous) 0.025 0.003 9.22 16976.48 <0.001 
Higher PWASI (continuous) 0.002 0.003 0.56 36618.59 0.578 
Hypertension (no) 0.031 0.031 1.01 35009.24 0.312 
Cholesterol high (no) 0.147 0.042 3.48 23571.01 <0.001 
Cardiovascular disease (no) 0.293 0.048 6.16 43171.64 <0.001 
Moderate exercise (no) 0.282 0.040 7.08 404.69 <0.001 
Diabetes (no) 0.163 0.059 2.75 16391.21 0.006 
Smoking status (never smoker)      
Smoker former 0.057 0.033 1.72 30952.80 0.086 
Smoker current 0.468 0.041 11.47 16082.11 <0.001 
Drinking status (never drinker)      
Drinker former 0.185 0.078 2.38 19950.08 0.017 
Drinker current 0.325 0.057 5.68 14668.67 <0.001 
Occupational noise exposure (no) 0.356 0.034 10.45 16224.25 <0.001 
Loud music exposure (no) 0.234 0.039 6.07 12583.91 <0.001 
Ototoxic medication use (no) 0.467 0.029 15.94 24253.23 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.153 0.096 1.59 42231.82 0.113 
Age band 3 x Female sex 0.201 0.095 2.12 38295.31 0.034 
Age band 4 x Female sex 0.168 0.098 1.72 37293.85 0.086 
Age band 5 x Female sex 0.228 0.099 2.31 32672.40 0.021 
Age band 6 x Female sex 0.295 0.114 2.58 24205.18 0.010 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , normal; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST6. Model output: o come In oo  heal h , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 3.728 0.070 53.30 47046.48 <0.001 
Group (SRTN/N *)      
SRTI/I 0.253 0.021 12.28 103878.98 <0.001 
SRTN/  0.299 0.080 3.76 95832.22 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.107 0.041 2.58 105229.38 0.010 
Age band 3 (50 54) 0.147 0.041 3.60 105100.18 <0.001 
Age band 4 (55 59) 0.231 0.040 5.74 107110.46 <0.001 
Age band 5 (60 64) 0.398 0.039 10.24 101160.13 <0.001 
Age band 6 (65 69) 0.597 0.042 14.25 104284.83 <0.001 
Sex (male) 0.103 0.043 2.40 107202.10 0.016 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.104 0.020 5.17 106364.22 <0.001 
Quintile 3 0.215 0.021 10.04 103263.00 <0.001 
Quintile 4 0.339 0.022 15.30 106334.32 <0.001 
Quintile 5 (most deprived) 0.486 0.029 16.96 99099.03 <0.001 
Ethnicity white (non white) 0.183 0.029 6.36 84075.46 <0.001 
Higher BMI (continuous) 0.093 0.002 57.59 58748.12 <0.001 
Higher PWASI (continuous) 0.016 0.002 6.64 63749.06 <0.001 
Hypertension (no) 0.168 0.016 10.34 104187.90 <0.001 
Cholesterol high (no) 0.377 0.021 18.23 106026.78 <0.001 
Cardiovascular disease (no) 0.749 0.026 29.16 102320.76 <0.001 
Moderate exercise (no) 0.344 0.020 16.77 560.86 <0.001 
Diabetes (no) 0.736 0.033 22.34 98952.97 <0.001 
Smoking status (never smoker)      
Smoker former 0.111 0.017 6.71 102761.07 <0.001 
Smoker current 0.704 0.024 29.68 96202.81 <0.001 
Drinking status (never drinker)      
Drinker former 0.252 0.050 5.06 94981.51 <0.001 
Drinker current 0.345 0.036 9.62 91492.78 <0.001 
Occupational noise exposure (no) 0.350 0.018 19.37 60304.65 <0.001 
Loud music exposure (no) 0.174 0.022 7.94 59411.69 <0.001 
Ototoxic medication use (no) 0.563 0.015 37.21 107517.18 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.146 0.058 2.53 107155.95 0.011 
Age band 3 x Female sex 0.104 0.056 1.85 109371.29 0.064 
Age band 4 x Female sex 0.104 0.055 1.90 109553.74 0.058 
Age band 5 x Female sex 0.119 0.052 2.27 108409.08 0.023 
Age band 6 x Female sex 0.261 0.056 4.69 108321.45 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST7. Model o : o come Dissatisfied with heal h , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 4.531 0.083 54.33 39860.62 <0.001 
Group (SRTN/N *)      
SRTI/I 0.190 0.026 7.38 82887.88 <0.001 
SRTN/  0.195 0.099 1.98 70178.78 0.048 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.110 0.051 2.16 94361.55 0.031 
Age band 3 (50 54) 0.240 0.051 4.74 99881.95 <0.001 
Age band 4 (55 59) 0.349 0.050 6.97 102525.63 <0.001 
Age band 5 (60 64) 0.668 0.049 13.55 102442.08 <0.001 
Age band 6 (65 69) 0.929 0.054 17.12 101884.12 <0.001 
Sex (male) 0.025 0.052 0.47 101137.28 0.637 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.036 0.026 1.40 95058.98 0.162 
Quintile 3 0.118 0.027 4.32 96200.77 <0.001 
Quintile 4 0.274 0.027 9.95 99292.05 <0.001 
Quintile 5 (most deprived) 0.342 0.034 9.95 76592.44 <0.001 
Ethnicity white (non white) 0.102 0.035 2.95 59719.27 0.003 
Higher BMI (continuous) 0.091 0.002 49.08 31784.85 <0.001 
Higher PWASI (continuous) 0.008 0.003 2.97 47342.76 0.003 
Hypertension (no) 0.102 0.021 4.92 99709.32 <0.001 
Cholesterol high (no) 0.270 0.026 10.37 96066.63 <0.001 
Cardiovascular disease (no) 0.640 0.029 21.74 91905.52 <0.001 
Moderate exercise (no) 0.358 0.025 14.54 646.88 <0.001 
Diabetes (no) 0.550 0.036 15.31 84062.13 <0.001 
Smoking status (never smoker)      
Smoker former 0.092 0.021 4.37 92018.90 <0.001 
Smoker current 0.459 0.029 15.84 87738.12 <0.001 
Drinking status (never drinker)      
Drinker former 0.415 0.058 7.16 68403.69 <0.001 
Drinker current 0.206 0.044 4.70 56040.32 <0.001 
Occupational noise exposure (no) 0.190 0.023 8.40 75299.89 <0.001 
Loud music exposure (no) 0.253 0.026 9.59 57439.02 <0.001 
Ototoxic medication use (no) 0.611 0.019 31.68 98253.69 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.232 0.070 3.33 94887.50 <0.001 
Age band 3 x Female sex 0.206 0.069 2.99 104390.06 0.003 
Age band 4 x Female sex 0.225 0.068 3.32 102176.01 <0.001 
Age band 5 x Female sex 0.262 0.065 4.00 105022.00 <0.001 
Age band 6 x Female sex 0.403 0.071 5.68 101941.31 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST8. Model o : o come Lonely , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 2.455 0.074 33.21 29496.03 <0.001 
Group (SRTN/N *)      
SRTI/I 0.182 0.022 8.16 71708.40 <0.001 
SRTN/  0.243 0.085 2.87 87762.99 0.004 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.024 0.046 0.52 85200.93 0.606 
Age band 3 (50 54) 0.061 0.046 1.34 79393.11 0.179 
Age band 4 (55 59) 0.203 0.046 4.43 71502.06 <0.001 
Age band 5 (60 64) 0.382 0.045 8.58 82564.24 <0.001 
Age band 6 (65 69) 0.635 0.050 12.76 73587.80 <0.001 
Sex (male) 0.341 0.045 7.57 72779.85 <0.001 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.126 0.022 5.70 85452.24 <0.001 
Quintile 3 0.253 0.023 10.91 67661.26 <0.001 
Quintile 4 0.401 0.024 16.97 76928.64 <0.001 
Quintile 5 (most deprived) 0.624 0.030 21.10 71842.44 <0.001 
Ethnicity white (non white) 0.138 0.030 4.59 69912.12 <0.001 
Higher BMI (continuous) 0.024 0.002 14.70 39371.74 <0.001 
Higher PWASI (continuous) 0.003 0.002 1.14 7247.40 0.256 
Hypertension (no) 0.080 0.017 4.60 73208.60 <0.001 
Cholesterol high (no) 0.012 0.024 0.49 82063.86 0.627 
Cardiovascular disease (no) 0.213 0.029 7.34 85018.40 <0.001 
Moderate exercise (no) 0.164 0.022 7.52 582.28 <0.001 
Diabetes (no) 0.216 0.037 5.90 77447.90 <0.001 
Smoking status (never smoker)      
Smoker former 0.010 0.018 0.57 78608.53 0.571 
Smoker current 0.396 0.025 15.80 76211.84 <0.001 
Drinking status (never drinker)      
Drinker former 0.290 0.053 5.49 57485.99 <0.001 
Drinker current 0.025 0.039 0.63 59997.58 0.525 
Occupational noise exposure (no) 0.254 0.020 12.66 52205.51 <0.001 
Loud music exposure (no) 0.222 0.023 9.54 42316.77 <0.001 
Ototoxic medication use (no) 0.302 0.016 18.37 92558.25 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.065 0.060 1.07 83196.99 0.282 
Age band 3 x Female sex 0.099 0.059 1.67 83100.74 0.095 
Age band 4 x Female sex 0.166 0.059 2.84 73120.59 0.005 
Age band 5 x Female sex 0.219 0.056 3.90 82121.01 <0.001 
Age band 6 x Female sex 0.389 0.062 6.30 75147.05 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST9. Model o : o come Unha , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 2.889 0.126 22.95 51425.11 <0.001 
Group (SRTN/N *)      
SRTI/I 0.176 0.041 4.30 80023.35 <0.001 
SRTN/  0.046 0.171 0.27 94825.85 0.787 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.102 0.068 1.49 98298.99 0.135 
Age band 3 (50 54) 0.039 0.069 0.56 95301.96 0.575 
Age band 4 (55 59) 0.226 0.071 3.16 97523.32 0.002 
Age band 5 (60 64) 0.615 0.073 8.40 96547.21 <0.001 
Age band 6 (65 69) 1.103 0.090 12.32 104571.39 <0.001 
Sex (male) 0.210 0.074 2.84 95297.40 0.005 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.074 0.042 1.75 99676.27 0.080 
Quintile 3 0.322 0.042 7.71 93093.15 <0.001 
Quintile 4 0.481 0.042 11.48 84600.97 <0.001 
Quintile 5 (most deprived) 0.556 0.051 10.86 83142.66 <0.001 
Ethnicity white (non white) 0.015 0.051 0.29 62793.84 0.771 
Higher BMI (continuous) 0.006 0.003 2.06 35663.97 0.040 
Higher PWASI (continuous) 0.002 0.004 0.42 63770.56 0.671 
Hypertension (no) 0.122 0.031 3.91 86108.58 <0.001 
Cholesterol high (no) 0.085 0.044 1.93 86633.62 0.054 
Cardiovascular disease (no) 0.192 0.052 3.71 94985.99 <0.001 
Moderate exercise (no) 0.327 0.036 9.15 905.14 <0.001 
Diabetes (no) 0.239 0.063 3.80 83085.22 <0.001 
Smoking status (never smoker)      
Smoker former 0.048 0.033 1.45 83730.51 0.146 
Smoker current 0.412 0.042 9.88 84513.54 <0.001 
Drinking status (never drinker)      
Drinker former 0.354 0.087 4.08 55994.48 <0.001 
Drinker current 0.205 0.068 3.02 60371.91 0.003 
Occupational noise exposure (no) 0.006 0.035 0.17 76420.57 0.867 
Loud music exposure (no) 0.362 0.037 9.71 52563.82 <0.001 
Ototoxic medication use (no) 0.295 0.030 9.97 98926.30 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.091 0.096 0.94 96815.56 0.348 
Age band 3 x Female sex 0.061 0.096 0.64 97838.97 0.525 
Age band 4 x Female sex 0.029 0.099 0.29 94903.63 0.770 
Age band 5 x Female sex 0.090 0.100 0.90 96194.57 0.367 
Age band 6 x Female sex 0.326 0.119 2.72 101178.74 0.006 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST10. Model o : o come Has difficulty following conversations in noise , 
comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 2.089 0.067 31.39 33753.81 <0.001 
Group (SRTN/N *)      
SRTI/I 0.685 0.018 37.70 77010.37 <0.001 
SRTN/  2.362 0.094 25.20 98284.75 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.324 0.041 7.99 66642.59 <0.001 
Age band 3 (50 54) 0.494 0.039 12.50 77172.09 <0.001 
Age band 4 (55 59) 0.686 0.039 17.75 67916.64 <0.001 
Age band 5 (60 64) 0.830 0.037 22.39 74886.38 <0.001 
Age band 6 (65 69) 1.012 0.039 25.81 72395.42 <0.001 
Sex (male) 0.011 0.043 0.26 69261.72 0.795 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.015 0.018 0.87 76487.18 0.383 
Quintile 3 0.012 0.019 0.65 76160.01 0.518 
Quintile 4 0.022 0.020 1.07 78312.17 0.282 
Quintile 5 (most deprived) 0.006 0.027 0.20 64733.28 0.838 
Ethnicity white (non white) 0.294 0.029 10.24 55848.09 <0.001 
Higher BMI (continuous) 0.008 0.001 5.20 35893.94 <0.001 
Higher PWASI (continuous) 0.005 0.002 2.66 23272.72 0.008 
Hypertension (no) 0.097 0.014 6.71 74329.24 <0.001 
Cholesterol high (no) 0.022 0.019 1.14 70065.65 0.254 
Cardiovascular disease (no) 0.108 0.025 4.35 69892.82 <0.001 
Moderate exercise (no) 0.088 0.017 5.11 989.23 <0.001 
Diabetes (no) 0.000 0.032 0.00 78021.17 0.996 
Smoking status (never smoker)      
Smoker former 0.109 0.015 7.53 70452.05 <0.001 
Smoker current 0.012 0.023 0.52 58204.93 0.604 
Drinking status (never drinker)      
Drinker former 0.179 0.048 3.71 58539.54 <0.001 
Drinker current 0.097 0.035 2.77 49109.33 0.006 
Occupational noise exposure (no) 0.527 0.016 32.39 54333.72 <0.001 
Loud music exposure (no) 0.497 0.020 24.90 46004.08 <0.001 
Ototoxic medication use (no) 0.153 0.014 10.94 63756.24 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.106 0.056 1.89 74170.59 0.058 
Age band 3 x Female sex 0.112 0.054 2.08 71064.92 0.038 
Age band 4 x Female sex 0.253 0.053 4.81 69784.80 <0.001 
Age band 5 x Female sex 0.280 0.050 5.62 71891.74 <0.001 
Age band 6 x Female sex 0.418 0.052 7.97 69867.59 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST11. Model o : o come Has tinnitus , comparator SRTN/N. 
Model variable Estimate SE z value df p value 
Intercept 2.642 0.085 31.26 33411.84 <0.001 
Group (SRTN/N *)      
SRTI/I 0.417 0.022 19.17 58849.67 <0.001 
SRTN/  1.397 0.072 19.45 74373.72 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.207 0.054 3.83 51468.65 <0.001 
Age band 3 (50 54) 0.358 0.052 6.85 47591.77 <0.001 
Age band 4 (55 59) 0.572 0.050 11.39 56098.19 <0.001 
Age band 5 (60 64) 0.750 0.048 15.58 53191.66 <0.001 
Age band 6 (65 69) 0.829 0.050 16.48 50334.21 <0.001 
Sex (male) 0.126 0.060 2.11 47344.28 0.035 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.046 0.022 2.09 70551.53 0.037 
Quintile 3 0.014 0.024 0.57 70179.40 0.566 
Quintile 4 0.083 0.026 3.25 56423.54 0.001 
Quintile 5 (most deprived) 0.159 0.033 4.80 63924.80 <0.001 
Ethnicity white (non white) 0.191 0.037 5.19 42703.08 <0.001 
Higher BMI (continuous) 0.002 0.002 0.96 27229.19 0.336 
Higher PWASI (continuous) 0.001 0.002 0.41 39965.83 0.685 
Hypertension (no) 0.048 0.018 2.62 77743.80 0.009 
Cholesterol high (no) 0.034 0.024 1.43 73676.78 0.153 
Cardiovascular disease (no) 0.098 0.029 3.35 70018.36 <0.001 
Moderate exercise (no) 0.019 0.022 0.88 1145.94 0.377 
Diabetes (no) 0.092 0.038 2.40 68832.60 0.017 
Smoking status (never smoker)      
Smoker former 0.007 0.018 0.39 63160.13 0.700 
Smoker current 0.128 0.030 4.30 60796.86 <0.001 
Drinking status (never drinker)      
Drinker former 0.190 0.058 3.28 60912.77 0.001 
Drinker current 0.051 0.043 1.18 67591.51 0.238 
Occupational noise exposure (no) 0.494 0.020 25.25 59801.18 <0.001 
Loud music exposure (no) 0.492 0.024 20.57 47264.80 <0.001 
Ototoxic medication use (no) 0.217 0.018 12.37 71740.08 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.081 0.078 1.04 49271.65 0.297 
Age band 3 x Female sex 0.057 0.074 0.78 47151.92 0.438 
Age band 4 x Female sex 0.018 0.071 0.25 54587.79 0.804 
Age band 5 x Female sex 0.073 0.067 1.08 54341.38 0.279 
Age band 6 x Female sex 0.107 0.070 1.55 49956.60 0.122 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST12. Model o : o come De e ed , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 2.621 0.118 22.13 8828.65 <0.001 
Group (SRTI/I *)      
SRTN/  0.242 0.154 1.57 36642.70 0.116 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.085 0.073 1.16 39719.76 0.245 
Age band 3 (50 54) 0.152 0.073 2.08 42047.25 0.037 
Age band 4 (55 59) 0.399 0.075 5.29 37134.07 <0.001 
Age band 5 (60 64) 0.818 0.077 10.56 34001.59 <0.001 
Age band 6 (65 69) 1.160 0.091 12.81 22164.43 <0.001 
Sex (male) 0.182 0.072 2.54 38437.57 0.011 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.101 0.042 2.39 35686.22 0.017 
Quintile 3 0.257 0.042 6.08 40801.57 <0.001 
Quintile 4 0.460 0.042 11.07 32392.85 <0.001 
Quintile 5 (most deprived) 0.638 0.049 13.14 25022.46 <0.001 
Ethnicity white (non white) 0.711 0.042 16.75 13323.67 <0.001 
Higher BMI (continuous) 0.025 0.003 9.22 16976.48 <0.001 
Higher PWASI (continuous) 0.002 0.003 0.56 36618.59 0.578 
Hypertension (no) 0.031 0.031 1.01 35009.24 0.312 
Cholesterol high (no) 0.147 0.042 3.48 23571.01 <0.001 
Cardiovascular disease (no) 0.293 0.048 6.16 43171.64 <0.001 
Moderate exercise (no) 0.282 0.040 7.08 404.69 <0.001 
Diabetes (no) 0.163 0.059 2.75 16391.21 0.006 
Smoking status (never smoker)      
Smoker former 0.057 0.033 1.72 30952.80 0.086 
Smoker current 0.468 0.041 11.47 16082.11 <0.001 
Drinking status (never drinker)      
Drinker former 0.185 0.078 2.38 19950.08 0.017 
Drinker current 0.325 0.057 5.68 14668.67 <0.001 
Occupational noise exposure (no) 0.356 0.034 10.45 16224.25 <0.001 
Loud music exposure (no) 0.234 0.039 6.07 12583.91 <0.001 
Ototoxic medication use (no) 0.467 0.029 15.94 24253.23 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.153 0.096 1.59 42231.82 0.113 
Age band 3 x Female sex 0.201 0.095 2.12 38295.31 0.034 
Age band 4 x Female sex 0.168 0.098 1.72 37293.85 0.086 
Age band 5 x Female sex 0.228 0.099 2.31 32672.40 0.021 
Age band 6 x Female sex 0.295 0.114 2.58 24205.18 0.010 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST13. Model o : o come In oo  heal h , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 3.476 0.071 48.99 47261.31 <0.001 
Group (SRTI/I *)      
SRTN/  0.046 0.081 0.57 97093.89 0.567 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.107 0.041 2.58 105229.38 0.010 
Age band 3 (50 54) 0.147 0.041 3.60 105100.18 <0.001 
Age band 4 (55 59) 0.231 0.040 5.74 107110.46 <0.001 
Age band 5 (60 64) 0.398 0.039 10.24 101160.13 <0.001 
Age band 6 (65 69) 0.597 0.042 14.25 104284.83 <0.001 
Sex (male) 0.103 0.043 2.40 107202.10 0.016 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.104 0.020 5.17 106364.22 <0.001 
Quintile 3 0.215 0.021 10.04 103263.00 <0.001 
Quintile 4 0.339 0.022 15.30 106334.32 <0.001 
Quintile 5 (most deprived) 0.486 0.029 16.96 99099.03 <0.001 
Ethnicity white (non white) 0.183 0.029 6.36 84075.46 <0.001 
Higher BMI (continuous) 0.093 0.002 57.59 58748.12 <0.001 
Higher PWASI (continuous) 0.016 0.002 6.64 63749.06 <0.001 
Hypertension (no) 0.168 0.016 10.34 104187.90 <0.001 
Cholesterol high (no) 0.377 0.021 18.23 106026.78 <0.001 
Cardiovascular disease (no) 0.749 0.026 29.16 102320.76 <0.001 
Moderate exercise (no) 0.344 0.020 16.77 560.86 <0.001 
Diabetes (no) 0.736 0.033 22.34 98952.97 <0.001 
Smoking status (never smoker)      
Smoker former 0.111 0.017 6.71 102761.07 <0.001 
Smoker current 0.704 0.024 29.68 96202.81 <0.001 
Drinking status (never drinker)      
Drinker former 0.252 0.050 5.06 94981.51 <0.001 
Drinker current 0.345 0.036 9.62 91492.78 <0.001 
Occupational noise exposure (no) 0.350 0.018 19.37 60304.65 <0.001 
Loud music exposure (no) 0.174 0.022 7.94 59411.69 <0.001 
Ototoxic medication use (no) 0.563 0.015 37.21 107517.18 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.146 0.058 2.53 107155.95 0.011 
Age band 3 x Female sex 0.104 0.056 1.85 109371.29 0.064 
Age band 4 x Female sex 0.104 0.055 1.90 109553.74 0.058 
Age band 5 x Female sex 0.119 0.052 2.27 108409.08 0.023 
Age band 6 x Female sex 0.261 0.056 4.69 108321.45 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST14. Model o : o come Dissatisfied with heal h , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 4.341 0.085 51.20 39213.07 <0.001 
Group (SRTI/I *)      
SRTN/  0.005 0.101 0.05 69367.14 0.960 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.110 0.051 2.16 94361.55 0.031 
Age band 3 (50 54) 0.240 0.051 4.74 99881.95 <0.001 
Age band 4 (55 59) 0.349 0.050 6.97 102525.63 <0.001 
Age band 5 (60 64) 0.668 0.049 13.55 102442.08 <0.001 
Age band 6 (65 69) 0.929 0.054 17.12 101884.12 <0.001 
Sex (male) 0.025 0.052 0.47 101137.28 0.637 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.036 0.026 1.40 95058.98 0.162 
Quintile 3 0.118 0.027 4.32 96200.77 <0.001 
Quintile 4 0.274 0.027 9.95 99292.05 <0.001 
Quintile 5 (most deprived) 0.342 0.034 9.95 76592.44 <0.001 
Ethnicity white (non white) 0.102 0.035 2.95 59719.27 0.003 
Higher BMI (continuous) 0.091 0.002 49.08 31784.85 <0.001 
Higher PWASI (continuous) 0.008 0.003 2.97 47342.76 0.003 
Hypertension (no) 0.102 0.021 4.92 99709.32 <0.001 
Cholesterol high (no) 0.270 0.026 10.37 96066.63 <0.001 
Cardiovascular disease (no) 0.640 0.029 21.74 91905.52 <0.001 
Moderate exercise (no) 0.358 0.025 14.54 646.88 <0.001 
Diabetes (no) 0.550 0.036 15.31 84062.13 <0.001 
Smoking status (never smoker)      
Smoker former 0.092 0.021 4.37 92018.90 <0.001 
Smoker current 0.459 0.029 15.84 87738.12 <0.001 
Drinking status (never drinker)      
Drinker former 0.415 0.058 7.16 68403.69 <0.001 
Drinker current 0.206 0.044 4.70 56040.32 <0.001 
Occupational noise exposure (no) 0.190 0.023 8.40 75299.89 <0.001 
Loud music exposure (no) 0.253 0.026 9.59 57439.02 <0.001 
Ototoxic medication use (no) 0.611 0.019 31.68 98253.69 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.232 0.070 3.33 94887.50 <0.001 
Age band 3 x Female sex 0.206 0.069 2.99 104390.06 0.003 
Age band 4 x Female sex 0.225 0.068 3.32 102176.01 <0.001 
Age band 5 x Female sex 0.262 0.065 4.00 105022.00 <0.001 
Age band 6 x Female sex 0.403 0.071 5.68 101941.31 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST15. Model output: o come Lonely , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 2.273 0.075 30.25 30186.13 <0.001 
Group (SRTI/I *)      
SRTN/  0.062 0.086 0.71 89821.12 0.476 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.024 0.046 0.52 85200.93 0.606 
Age band 3 (50 54) 0.061 0.046 1.34 79393.11 0.179 
Age band 4 (55 59) 0.203 0.046 4.43 71502.06 <0.001 
Age band 5 (60 64) 0.382 0.045 8.58 82564.24 <0.001 
Age band 6 (65 69) 0.635 0.050 12.76 73587.80 <0.001 
Sex (male) 0.341 0.045 7.57 72779.85 <0.001 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.126 0.022 5.70 85452.24 <0.001 
Quintile 3 0.253 0.023 10.91 67661.26 <0.001 
Quintile 4 0.401 0.024 16.97 76928.64 <0.001 
Quintile 5 (most deprived) 0.624 0.030 21.10 71842.44 <0.001 
Ethnicity white (non white) 0.138 0.030 4.59 69912.12 <0.001 
Higher BMI (continuous) 0.024 0.002 14.70 39371.74 <0.001 
Higher PWASI (continuous) 0.003 0.002 1.14 7247.40 0.256 
Hypertension (no) 0.080 0.017 4.60 73208.60 <0.001 
Cholesterol high (no) 0.012 0.024 0.49 82063.86 0.627 
Cardiovascular disease (no) 0.213 0.029 7.34 85018.40 <0.001 
Moderate exercise (no) 0.164 0.022 7.52 582.28 <0.001 
Diabetes (no) 0.216 0.037 5.90 77447.90 <0.001 
Smoking status (never smoker)      
Smoker former 0.010 0.018 0.57 78608.53 0.571 
Smoker current 0.396 0.025 15.80 76211.84 <0.001 
Drinking status (never drinker)      
Drinker former 0.290 0.053 5.49 57485.99 <0.001 
Drinker current 0.025 0.039 0.63 59997.58 0.525 
Occupational noise exposure (no) 0.254 0.020 12.66 52205.51 <0.001 
Loud music exposure (no) 0.222 0.023 9.54 42316.77 <0.001 
Ototoxic medication use (no) 0.302 0.016 18.37 92558.25 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.065 0.060 1.07 83196.99 0.282 
Age band 3 x Female sex 0.099 0.059 1.67 83100.74 0.095 
Age band 4 x Female sex 0.166 0.059 2.84 73120.59 0.005 
Age band 5 x Female sex 0.219 0.056 3.90 82121.01 <0.001 
Age band 6 x Female sex 0.389 0.062 6.30 75147.05 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST16. Model o : o come Unha , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 2.713 0.128 21.15 50958.33 <0.001 
Group (SRTI/I *)      
SRTN/  0.222 0.174 1.28 91233.17 0.202 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.102 0.068 1.49 98298.99 0.135 
Age band 3 (50 54) 0.039 0.069 0.56 95301.96 0.575 
Age band 4 (55 59) 0.226 0.071 3.16 97523.32 0.002 
Age band 5 (60 64) 0.615 0.073 8.40 96547.21 <0.001 
Age band 6 (65 69) 1.103 0.090 12.32 104571.39 <0.001 
Sex (male) 0.210 0.074 2.84 95297.40 0.005 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.074 0.042 1.75 99676.27 0.080 
Quintile 3 0.322 0.042 7.71 93093.15 <0.001 
Quintile 4 0.481 0.042 11.48 84600.97 <0.001 
Quintile 5 (most deprived) 0.556 0.051 10.86 83142.66 <0.001 
Ethnicity white (non white) 0.015 0.051 0.29 62793.84 0.771 
Higher BMI (continuous) 0.006 0.003 2.06 35663.97 0.040 
Higher PWASI (continuous) 0.002 0.004 0.42 63770.56 0.671 
Hypertension (no) 0.122 0.031 3.91 86108.58 <0.001 
Cholesterol high (no) 0.085 0.044 1.93 86633.62 0.054 
Cardiovascular disease (no) 0.192 0.052 3.71 94985.99 <0.001 
Moderate exercise (no) 0.327 0.036 9.15 905.14 <0.001 
Diabetes (no) 0.239 0.063 3.80 83085.22 <0.001 
Smoking status (never smoker)      
Smoker former 0.048 0.033 1.45 83730.51 0.146 
Smoker current 0.412 0.042 9.88 84513.54 <0.001 
Drinking status (never drinker)      
Drinker former 0.354 0.087 4.08 55994.48 <0.001 
Drinker current 0.205 0.068 3.02 60371.91 0.003 
Occupational noise exposure (no) 0.006 0.035 0.17 76420.57 0.867 
Loud music exposure (no) 0.362 0.037 9.71 52563.82 <0.001 
Ototoxic medication use (no) 0.295 0.030 9.97 98926.30 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.091 0.096 0.94 96815.56 0.348 
Age band 3 x Female sex 0.061 0.096 0.64 97838.97 0.525 
Age band 4 x Female sex 0.029 0.099 0.29 94903.63 0.770 
Age band 5 x Female sex 0.090 0.100 0.90 96194.57 0.367 
Age band 6 x Female sex 0.326 0.119 2.72 101178.74 0.006 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST17. Model o : o come Has difficulty following conversations in noise , 
comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 1.404 0.067 20.94 37773.93 <0.001 
Group (SRTI/I *)      
SRTN/  1.676 0.095 17.69 97829.47 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.324 0.041 7.99 66642.59 <0.001 
Age band 3 (50 54) 0.494 0.039 12.50 77172.09 <0.001 
Age band 4 (55 59) 0.686 0.039 17.75 67916.64 <0.001 
Age band 5 (60 64) 0.830 0.037 22.39 74886.38 <0.001 
Age band 6 (65 69) 1.012 0.039 25.81 72395.42 <0.001 
Sex (male) 0.011 0.043 0.26 69261.72 0.795 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.015 0.018 0.87 76487.18 0.383 
Quintile 3 0.012 0.019 0.65 76160.01 0.518 
Quintile 4 0.022 0.020 1.07 78312.17 0.282 
Quintile 5 (most deprived) 0.006 0.027 0.20 64733.28 0.838 
Ethnicity white (non white) 0.294 0.029 10.24 55848.09 <0.001 
Higher BMI (continuous) 0.008 0.001 5.20 35893.94 <0.001 
Higher PWASI (continuous) 0.005 0.002 2.66 23272.72 0.008 
Hypertension (no) 0.097 0.014 6.71 74329.24 <0.001 
Cholesterol high (no) 0.022 0.019 1.14 70065.65 0.254 
Cardiovascular disease (no) 0.108 0.025 4.35 69892.82 <0.001 
Moderate exercise (no) 0.088 0.017 5.11 989.23 <0.001 
Diabetes (no) 0.000 0.032 0.00 78021.17 0.996 
Smoking status (never smoker)      
Smoker former 0.109 0.015 7.53 70452.05 <0.001 
Smoker current 0.012 0.023 0.52 58204.93 0.604 
Drinking status (never drinker)      
Drinker former 0.179 0.048 3.71 58539.54 <0.001 
Drinker current 0.097 0.035 2.77 49109.33 0.006 
Occupational noise exposure (no) 0.527 0.016 32.39 54333.72 <0.001 
Loud music exposure (no) 0.497 0.020 24.90 46004.08 <0.001 
Ototoxic medication use (no) 0.153 0.014 10.94 63756.24 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.106 0.056 1.89 74170.59 0.058 
Age band 3 x Female sex 0.112 0.054 2.08 71064.92 0.038 
Age band 4 x Female sex 0.253 0.053 4.81 69784.80 <0.001 
Age band 5 x Female sex 0.280 0.050 5.62 71891.74 <0.001 
Age band 6 x Female sex 0.418 0.052 7.97 69867.59 <0.001 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
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TABLE ST18. Model o : o come Has tinnitus , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 2.225 0.085 26.06 33562.22 <0.001 
Group (SRTI/I *)      
SRTN/  0.980 0.074 13.31 69142.46 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.207 0.054 3.83 51468.65 <0.001 
Age band 3 (50 54) 0.358 0.052 6.85 47591.77 <0.001 
Age band 4 (55 59) 0.572 0.050 11.39 56098.19 <0.001 
Age band 5 (60 64) 0.750 0.048 15.58 53191.66 <0.001 
Age band 6 (65 69) 0.829 0.050 16.48 50334.21 <0.001 
Sex (male) 0.126 0.060 2.11 47344.28 0.035 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.046 0.022 2.09 70551.53 0.037 
Quintile 3 0.014 0.024 0.57 70179.40 0.566 
Quintile 4 0.083 0.026 3.25 56423.54 0.001 
Quintile 5 (most deprived) 0.159 0.033 4.80 63924.80 <0.001 
Ethnicity white (non white) 0.191 0.037 5.19 42703.08 <0.001 
Higher BMI (continuous) 0.002 0.002 0.96 27229.19 0.336 
Higher PWASI (continuous) 0.001 0.002 0.41 39965.83 0.685 
Hypertension (no) 0.048 0.018 2.62 77743.80 0.009 
Cholesterol high (no) 0.034 0.024 1.43 73676.78 0.153 
Cardiovascular disease (no) 0.098 0.029 3.35 70018.36 <0.001 
Moderate exercise (no) 0.019 0.022 0.88 1145.94 0.377 
Diabetes (no) 0.092 0.038 2.40 68832.60 0.017 
Smoking status (never smoker)      
Smoker former 0.007 0.018 0.39 63160.13 0.700 
Smoker current 0.128 0.030 4.30 60796.86 <0.001 
Drinking status (never drinker)      
Drinker former 0.190 0.058 3.28 60912.77 0.001 
Drinker current 0.051 0.043 1.18 67591.51 0.238 
Occupational noise exposure (no) 0.494 0.020 25.25 59801.18 <0.001 
Loud music exposure (no) 0.492 0.024 20.57 47264.80 <0.001 
Ototoxic medication use (no) 0.217 0.018 12.37 71740.08 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.081 0.078 1.04 49271.65 0.297 
Age band 3 x Female sex 0.057 0.074 0.78 47151.92 0.438 
Age band 4 x Female sex 0.018 0.071 0.25 54587.79 0.804 
Age band 5 x Female sex 0.073 0.067 1.08 54341.38 0.279 
Age band 6 x Female sex 0.107 0.070 1.55 49956.60 0.122 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
Stiffness Index; SE, standard error; SRT, speech reception threshold. 
  
22/23 
TABLE ST19. Model o : o come Uses hearing aids , comparator SRTI/I. 
Model variable Estimate SE z value df p value 
Intercept 5.053 0.413 12.22 62742.03 <0.001 
Group (SRTI/I *)      
SRTN/  1.051 0.095 11.05 109511.03 <0.001 
Age (Age band 1, 40 44 years old)      
Age band 2 (45 49) 0.820 0.394 2.08 103673.23 0.038 
Age band 3 (50 54) 0.821 0.379 2.17 101545.05 0.030 
Age band 4 (55 59) 1.087 0.360 3.02 99996.10 0.003 
Age band 5 (60 64) 1.425 0.348 4.10 98874.64 <0.001 
Age band 6 (65 69) 1.790 0.346 5.17 98594.75 <0.001 
Sex (male) 0.272 0.436 0.62 96502.10 0.532 
Material deprivation      
(Quintile 1, least deprived)      
Quintile 2 0.026 0.073 0.35 108555.62 0.723 
Quintile 3 0.035 0.081 0.44 109571.43 0.660 
Quintile 4 0.108 0.085 1.28 110029.12 0.202 
Quintile 5 (most deprived) 0.138 0.107 1.30 106717.18 0.195 
Ethnicity white (non white) 1.004 0.129 7.80 107069.71 <0.001 
Higher BMI (continuous) 0.000 0.006 0.02 27133.82 0.985 
Higher PWASI (continuous) 0.006 0.008 0.81 71910.53 0.415 
Hypertension (no) 0.114 0.062 1.84 109815.43 0.065 
Cholesterol high (no) 0.021 0.068 0.31 112652.41 0.757 
Cardiovascular disease (no) 0.017 0.081 0.22 112051.10 0.830 
Moderate exercise (no) 0.151 0.080 1.89 589.70 0.058 
Diabetes (no) 0.148 0.098 1.51 109137.09 0.132 
Smoking status (never smoker)      
Smoker former 0.095 0.060 1.59 104914.93 0.111 
Smoker current 0.283 0.103 2.76 101532.32 0.006 
Drinking status (never drinker)      
Drinker former 0.061 0.178 0.34 111125.79 0.730 
Drinker current 0.028 0.128 0.22 110908.42 0.825 
Occupational noise exposure (no) 0.581 0.062 9.39 92804.89 <0.001 
Loud music exposure (no) 0.282 0.085 3.33 59712.36 <0.001 
Ototoxic medication use (no) 0.299 0.058 5.14 112781.06 <0.001 
Age band sex interaction      
(Age band 1 x Male sex)      
Age band 2 x Female sex 0.912 0.536 1.70 99811.42 0.089 
Age band 3 x Female sex 0.224 0.487 0.46 101418.87 0.646 
Age band 4 x Female sex 0.534 0.467 1.15 99288.71 0.252 
Age band 5 x Female sex 0.389 0.446 0.87 97126.84 0.384 
Age band 6 x Female sex 0.555 0.443 1.25 97649.47 0.211 
* Reference levels for the corresponding predictor variables are shown in brackets. 
BMI, Body Mass Index; df, degrees of freedom; I , i ai ed; N , a ; PWASI, Pulse Wave Arterial 
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